The stock price of TrueBlue Inc (NYSE: TBI) has jumped by 0.91% compared to previous close of $6.59. Despite this, the company has seen a gain of 1.37% in its stock price over the last five trading days. businesswire.com reported 2025-07-02 that TACOMA, Wash.–(BUSINESS WIRE)–TrueBlue (NYSE: TBI), a leading provider of specialized workforce solutions, today announced that its global talent solutions brand, PeopleScout, has been named a Leader in Everest Group’s Recruitment Process Outsourcing (RPO) Services PEAK Matrix® Assessment 2025 – Global. “This recognition highlights the value and impact of the talent solutions TrueBlue provides to countless businesses,” said Taryn Owen, President and CEO of TrueBlue. “Leveraging a powerful com.
Is It Worth Investing in TrueBlue Inc (NYSE: TBI) Right Now?
Company’s 36-month beta value is 1.55.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy”, 1 as “overweight”, 1 as “hold”, and 0 as “sell”.
The public float for TBI is 28.53M, and currently, short sellers hold a 2.85% ratio of that floaft. The average trading volume of TBI on July 04, 2025 was 341.40K shares.
TBI’s Market Performance
TBI’s stock has seen a 1.37% increase for the week, with a 10.83% rise in the past month and a 17.91% gain in the past quarter. The volatility ratio for the week is 4.31%, and the volatility levels for the past 30 days are at 5.26% for TrueBlue Inc The simple moving average for the last 20 days is 0.99% for TBI’s stock, with a simple moving average of -1.05% for the last 200 days.
Analysts’ Opinion of TBI
Many brokerage firms have already submitted their reports for TBI stocks, with BMO Capital Markets repeating the rating for TBI by listing it as a “Outperform”. The predicted price for TBI in the upcoming period, according to BMO Capital Markets is $20 based on the research report published on May 22, 2023 of the previous year 2023.
BMO Capital Markets, on the other hand, stated in their research note that they expect to see TBI reach a price target of $20, previously predicting the price at $36. The rating they have provided for TBI stocks is “Market Perform” according to the report published on May 26th, 2022.
Robert W. Baird gave a rating of “Outperform” to TBI, setting the target price at $29 in the report published on April 27th of the previous year.
TBI Trading at 17.00% from the 50-Day Moving Average
After a stumble in the market that brought TBI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -45.89% of loss for the given period.
Volatility was left at 5.26%, however, over the last 30 days, the volatility rate increased by 4.31%, as shares surge +11.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +52.17% upper at present.
During the last 5 trading sessions, TBI rose by +1.37%, which changed the moving average for the period of 200-days by -13.19% in comparison to the 20-day moving average, which settled at $6.59. In addition, TrueBlue Inc saw -36.12% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TBI starting from Schweihs Carl, who purchase 2,500 shares at the price of $5.25 back on Mar 12 ’25. After this action, Schweihs Carl now owns 169,051 shares of TrueBlue Inc, valued at $13,125 using the latest closing price.
Owen Taryn R, the CEO and President of TrueBlue Inc, purchase 12,735 shares at $5.94 during a trade that took place back on Feb 26 ’25, which means that Owen Taryn R is holding 414,932 shares at $75,646 based on the most recent closing price.
Stock Fundamentals for TBI
Current profitability levels for the company are sitting at:
- -0.02% for the present operating margin
- 0.3% for the gross margin
The net margin for TrueBlue Inc stands at -0.11%. The total capital return value is set at -0.05%. Equity return is now at value -36.98%, with -17.73% for asset returns.
Based on TrueBlue Inc (TBI), the company’s capital structure generated 0.28 points at debt to capital in total, while cash flow to debt ratio is standing at -0.22. The debt to equity ratio resting at 0.38. The interest coverage ratio of the stock is -13.04.
Currently, EBITDA for the company is -3.54 million with net debt to EBITDA at -4.65. When we switch over and look at the enterprise to sales, we see a ratio of 0.23. The receivables turnover for the company is 5.71for trailing twelve months and the total asset turnover is 1.81. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.
Conclusion
In a nutshell, TrueBlue Inc (TBI) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
